Hospitals Pharmaceutical Companies Specialty Pharmacies 
Omnicell
FEBRUARY 13, 2023
Last month, a federal appeals court in Philadelphia sided largely with pharmaceutical companies in the ongoing showdown involving access to 340B discount pricing via contract pharmacies. What does the ruling mean for your hospital pharmacy program? The three-judge panel for the U.S.
PQA
OCTOBER 16, 2024
She currently serves as the National Executive Committee (NEC) Student President under the National Association of Specialty Pharmacy (NASP), promoting advocacy of the field of specialty pharmacy to students around the country. What inspired you to complete an APPE rotation in association management?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Omnicell
MARCH 27, 2023
Ted Slafsky Founder and Principal of Wexford Solutions, Publisher, 340B Report In the past 18 months, the 340B contract pharmacy program has seemingly fractured into 17 programs, one governed by the federal government and 16 others with their own standards determined by pharmaceutical manufacturers.
PQA
MARCH 28, 2024
Our members include community and specialty pharmacy organizations, pharmacists and other healthcare providers, pharmacies, health plans, pharmacy benefit managers, life sciences, technology vendors, government agencies, health information technology partners, researchers, accrediting organizations and academia.
PQA
MARCH 27, 2024
Our members include community and specialty pharmacy organizations, pharmacists and other healthcare providers, pharmacies, health plans, pharmacy benefit managers, life sciences, technology vendors, government agencies, health information technology partners, researchers, accrediting organizations and academia.
The Checkup by Singlecare
SEPTEMBER 10, 2024
It is made by the pharmaceutical company Amgen, Inc. In April of 2024, the FDA approved Selarsdi (ustekinumab-aekn), a Stelara biosimilar made by the pharmaceutical companies Alvotech and Teva Pharmaceuticals. Wezlana (ustekinumab-auub) was FDA approved on Oct. 31, 2023, as an interchangeable biosimilar to Stelara.
The Checkup by Singlecare
AUGUST 6, 2024
Avsola vs. Remicade: Key differences Remicade, made by the pharmaceutical company Janssen Biotech, was approved by the Food and Drug Administration (FDA) in 1998. In some cases, Avsola and Remicade may be filled at a specialty pharmacy. Continue reading to learn more about Avsola and Remicade.
Expert insights. Personalized for you.
74 
Let's personalize your content